---
id: 027
title: Ceftriaxone Clinical Uses and Dosing
category: antimicrobials
subcategory: cephalosporins
tags: [ceftriaxone, 3rd-generation, CAP, meningitis, gonorrhea, CRIMES]
difficulty: medium
---

## Question

What are the key clinical uses of **ceftriaxone**, and what are important dosing considerations? Use **CRIMES** mnemonic.

## Answer

**CRIMES mnemonic for ceftriaxone uses:**

- **C**ommunity-acquired pneumonia (outpatient)
- **R**ocephin = brand name (once-daily dosing advantage)
- **I**nfective endocarditis (*Strep viridans*, HACEK)
- **M**eningitis (bacterial - empiric + *S. pneumoniae*, *N. meningitidis*)
- **E**ndovascular infections (syphilis, Lyme with CNS)
- **S**exually transmitted infections (gonorrhea, chancroid)

### **Spectrum:**
- **Excellent:** *S. pneumoniae*, *S. pyogenes*, *N. meningitidis*, *N. gonorrhoeae*, *H. influenzae*
- **Good:** Enterobacterales (*E. coli*, *Klebsiella*, *Proteus*)
- **Poor:** MSSA (use cefazolin instead), *Pseudomonas* (use ceftazidime)
- **NO activity:** MRSA, Enterococcus, *Listeria*, atypicals, anaerobes

### **Dosing:**

| Indication | Dose | Duration | Notes |
|------------|------|----------|-------|
| **CAP (outpatient)** | 1g IV/IM daily | 5-7 days | + macrolide (azithromycin) |
| **Meningitis** | 2g IV q12h | 10-14 days | ± vancomycin for *S. pneumoniae* |
| **Gonorrhea (uncomplicated)** | 500mg IM × 1 | Single dose | (Updated: 2024 CDC uses cefixime) |
| **Endocarditis** | 2g IV daily | 4 weeks | *Strep viridans* (native valve) |
| **Lyme disease (CNS)** | 2g IV daily | 14-28 days | Neuroborreliosis |

## Key Points

- **Once-daily dosing:** Long half-life (6-9 hours) allows q24h administration
- **CNS penetration:** Good (inflamed meninges) - ideal for meningitis
- **Biliary excretion:** Can cause biliary sludging/pseudocholelithiasis (especially children, TPN)
- **Avoid in neonates:** Risk of kernicterus (displaces bilirubin from albumin)
- **NO calcium-containing IV solutions:** Forms precipitate (contraindicated)

### **Ceftriaxone vs Cefotaxime:**
- Both 3rd-gen with similar spectrum
- **Ceftriaxone:** Once-daily, longer half-life, biliary excretion
- **Cefotaxime:** q6-8h dosing, renal excretion, safer in neonates

## Sources

- [StatPearls: Cephalosporins]
- [IBCC: Antibiotics - Ceftriaxone]
- [Cureus 2024: Cefotaxime vs Ceftriaxone Comparison]

## Media

N/A
